Locations:
Search IconSearch
October 24, 2016/Digestive/Q&A

Hot Trends at ASMBS 2016

Q&A with ASMBS President Raul Rosenthal, MD

16-ddi-2011-obesity-week-cqd-650×450

President of the American Society for Metabolic and Bariatric Surgery (ASMBS), Raul Rosenthal, MD, Director of Cleveland Clinic Florida’s Bariatric and Metabolic Institute, reveals some key trends that will be discussed during this year’s ASMBS meeting in New Orleans.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Consult QD:

What are you looking forward to at this year’s ASMBS meeting and why?

Dr. Rosenthal:

We received an all-time-high number of abstracts, and the ASMBS meeting itself will be the largest gathering in its history. As president, I have very high expectations for what we will see and learn during this 33rd anniversary of our society.

We will see a combination of recently approved U.S. FDA technologies, as well as hear presentations about new guidelines to treat patients with diabetes and other medical conditions related to obesity. Additionally, we will better understand surgical methods and their successes.

Consult QD:

Can you give us a quick overview of some of the FDA-approved technologies and surgical methods that will be showcased?

Dr. Rosenthal:

There will be a tremendous range of knowledge gained from ASMBS posters, presentations and surgical forums. At ASMBS, we will:

  • Learn how to prevent obesity starting at a young age. Interventions include encouraging healthy meals and regular physical activity, as well as incorporating successful government programs such as the First Lady’s Let’s Move! initiative into daily life.
  • Encourage obesity awareness and education at the community level by promoting participation in the 30 nationwide Walk from ObesitySM walkathons
  • Gain insight as to how to manage short- and long-term complications from surgery
  • Discuss two recently approved FDA procedures for obesity, AspireAssist and the intragastric balloon
  • Discuss vagal blocking therapy, a new, FDA-approved device for weight loss, which involves intermittent vagal blocking to regulate stomach functions
  • Utilize surgical forums to debate various benefits for specific weight-loss surgeries such as single anastomosis duodeno-ileostomy and single anastomosis gastric bypass

Advertisement

Consult QD:

Are there any other overall trends you expect will be of interest at ASMBS this year?

Dr. Rosenthal:

At ASMBS, we will highlight an analysis of over 200 claims to better understand why physicians are subject to litigation when performing bariatric surgeryPreview. Despite bariatric surgery being one of the safest surgical approaches available to our patients, complications may result. Investigating why these complications occur and what we can do differently is key.

Consult QD:

Looking back on your year as ASMBS president, what has the experience meant to you, and what would you say were your biggest accomplishments or takeaways?

Dr. Rosenthal:

Being the president of ASMBS has been the greatest honor I have had thus far as a professional. During my presidency, we started six new committees, continued the important work of 56 projects, created new curricula for surgical training, and developed new carepaths to improve outcomes and decrease costs of bariatric procedures. We also conducted a nationwide survey to better understand the perception of obesity in our country. I’ll share these insights during my presidential address in New Orleans on Thursday, Nov. 3.

Dr. Rosenthal’s successful tenure as president comes to an end at this meeting. Stacy Brethauer, MD, bariatric surgeon at Cleveland Clinic’s Bariatric and Metabolic Institute in Ohio, will succeed him.

Follow Cleveland Clinic on Twitter at the 2016 ASMBS meeting, using the hashtag #OW2016.

Advertisement

Related Articles

22-DDI-2982561 – New GI chair article – DrMichelle Kim CQD 650×450-v2
August 1, 2022/Digestive/Q&A
Making History: Michelle Kang Kim, MD, PhD, is Cleveland Clinic’s First Female Chair of Gastroenterology

Addressing gender and diversity issues are among her priorities

20-DDI-1897975-Rizk_ACO-FAQs-CQD-650×450
July 10, 2020/Digestive/Q&A
Frequently Asked Questions About Accountable Care Organizations

What is an accountable care organization and how does it work?

CCAD_650x450
February 3, 2020/Digestive/Q&A
Digestive Disease Institute in Abu Dhabi Growing By Leaps and Bounds

Specialty care programs quickly expanding to meet the region’s needs

EPN image 650×450
August 13, 2019/Digestive/Q&A
What You Need to Know About Endoscopic Pancreatic Necrosectomy

Minimally invasive technique is highly successful for managing pancreatic necrosis

19-DDI-329-Hull-President-CQD-2
May 30, 2019/Digestive/Q&A
What’s Ahead for ASCRS? Mentoring, Unifying and More Social Media

Incoming president Tracy Hull, MD, discusses her goals for the colorectal surgery society

19-DDI-210-drVargoPortrait-650×450
April 29, 2019/Digestive/Q&A
Touching Base with the ASGE’s Incoming President

Cleveland Clinic’s John Vargo, MD, MPH, on his leadership plans for the endoscopy society

18-DDI-2630-reguieroPtnt-650×450
February 22, 2019/Digestive/Q&A
“It Takes a Village” to Provide Exceptional Patient Care

Build the team and listen to its members, this gastroenterology leader advises

Ad